Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suresh Senan

Showing results (271-280 of 348) with videos related to

Pageof 35
Sort By:
Lung Cancer (Amsterdam, Netherlands)|August 27, 2013
Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factorsGwendolyn H M J Griffioen, Daniel Toguri, Max Dahele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer GroupsBerend J Slotman, Murielle E Mauer, Andrew Bottomley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2023
Same-day adaptive palliative radiotherapy without prior CT simulation: Early outcomes in the FAST-METS studyKoen J Nelissen, Eva Versteijne, Suresh Senan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 3, 2021
Impact of daily plan adaptation on organ-at-risk normal tissue complication probability for adrenal lesions undergoing stereotactic ablative radiation therapyHanbo Chen, Famke L Schneiders, Anna M E Bruynzeel, et al.
Lung Cancer (Amsterdam, Netherlands)|November 26, 2002
Can errors in reconstructing pre-chemotherapy target volumes contribute to the inferiority of sequential chemoradiation in stage III non-small cell lung cancer (NSCLC)?Frank J Lagerwaard, Paul J M van de Vaart, Peter W J Voet, et al.
Current Medical Research and Opinion|May 25, 2019
Healthcare resource utilization and associated cost analysis of the PROCLAIM study in patients with stage III non-small-cell lung cancerRamaswamy Govindan, Suresh Senan, Nicolas Dickgreber, et al.
Cancer Science|September 21, 2025
Durvalumab Post Concurrent Chemoradiotherapy in Japanese Patients With Limited-Stage Small-Cell Lung Cancer in the Phase 3 ADRIATIC TrialYoshitaka Zenke, Yoshimasa Shiraishi, Yasushi Goto, et al.
Lung Cancer (Amsterdam, Netherlands)|January 30, 2013
Concurrent chemoradiotherapy for large-volume locally-advanced non-small cell lung cancerTerry G Wiersma, Max Dahele, Wilko F A R Verbakel, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 2012
In reply to Zagar and MarksFeng Ming Spring Kong, Timothy Ritter, Douglas Quint, et al.
International Journal of Radiation Oncology, Biology, Physics|June 12, 2012
Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysisDavid A Palma, Suresh Senan, Kayoko Tsujino, et al.
Pageof 35

Showing results (271-280 of 348) with videos related to

Sort By:
Pageof 35
Lung Cancer (Amsterdam, Netherlands)|August 27, 2013
Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factorsGwendolyn H M J Griffioen, Daniel Toguri, Max Dahele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer GroupsBerend J Slotman, Murielle E Mauer, Andrew Bottomley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2023
Same-day adaptive palliative radiotherapy without prior CT simulation: Early outcomes in the FAST-METS studyKoen J Nelissen, Eva Versteijne, Suresh Senan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 3, 2021
Impact of daily plan adaptation on organ-at-risk normal tissue complication probability for adrenal lesions undergoing stereotactic ablative radiation therapyHanbo Chen, Famke L Schneiders, Anna M E Bruynzeel, et al.
Lung Cancer (Amsterdam, Netherlands)|November 26, 2002
Can errors in reconstructing pre-chemotherapy target volumes contribute to the inferiority of sequential chemoradiation in stage III non-small cell lung cancer (NSCLC)?Frank J Lagerwaard, Paul J M van de Vaart, Peter W J Voet, et al.
Current Medical Research and Opinion|May 25, 2019
Healthcare resource utilization and associated cost analysis of the PROCLAIM study in patients with stage III non-small-cell lung cancerRamaswamy Govindan, Suresh Senan, Nicolas Dickgreber, et al.
Cancer Science|September 21, 2025
Durvalumab Post Concurrent Chemoradiotherapy in Japanese Patients With Limited-Stage Small-Cell Lung Cancer in the Phase 3 ADRIATIC TrialYoshitaka Zenke, Yoshimasa Shiraishi, Yasushi Goto, et al.
Lung Cancer (Amsterdam, Netherlands)|January 30, 2013
Concurrent chemoradiotherapy for large-volume locally-advanced non-small cell lung cancerTerry G Wiersma, Max Dahele, Wilko F A R Verbakel, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 2012
In reply to Zagar and MarksFeng Ming Spring Kong, Timothy Ritter, Douglas Quint, et al.
International Journal of Radiation Oncology, Biology, Physics|June 12, 2012
Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysisDavid A Palma, Suresh Senan, Kayoko Tsujino, et al.
Pageof 35